Medalytix understands the pressure points of managing a screening programme in which managers have to juggle the twin requirements of quality and cost effectiveness. Accepted screening process is currently manual, time consuming and complex. A particular issue in screening is the lack of trained graders, their variable performance and the sheer volume of photos that need to be analysed (almost 10 million each year in the UK alone). As the number of people with diabetes is growing at some 6% annually, the problem of dealing with the sheer volume of images can only get worse. Crucially, each year only half of these photos show signs of disease.
iGradingM is an active screening management system that brings peace of mind at every phase in the screening cycle. It has the unprecedented potential to increase screening capacity by up to 100%, without having to bring in expensive additional grading support. The introduction of an automated filtration step to remove normal images leaves healthcare professionals free to focus attention on the images they know have a potential problem – thereby rapidly identifying the patients who may need intervention.
Use of iGradingM provides a safe, consistent initial grading step for the screening programme and removes the risk of grading variability.
iGradingM is installed and working in the National Diabetic Retinopathy Screening Programme in NHS Scotland. This move was made to deliver significant service savings, improve clinical safety and service quality to patients now and in the future.